Chronos Archive seal
The Human Record

George H. W. Bush

Case HR-ML018 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
June 12, 1924 – November 30, 2018
Synthetic DOB
1959-06-12
Index visit
2026-05-08 at age 66
Synthetic MRN
HR-ML018-SYN

Teaching objective: Manage new paroxysmal atrial fibrillation triggered by Graves' hyperthyroidism in a fit 66-year-old: rate control with a beta-blocker and no cardioversion or antiarrhythmic while thyrotoxic, CHA2DS2-VASc and HAS-BLED scoring with a shared anticoagulation decision, methimazole pretreatment with safety monitoring, radioactive iodine as definitive treatment, recognition of the expected hypothyroidism afterwards, levothyroxine started at a cautious dose and titrated by TSH, confirmation of sustained sinus rhythm before stopping anticoagulation, on the CMID atrial fibrillation and hypothyroidism schedules with the 2023 ACC/AHA/ACCP/HRS and ATA guidelines.

Historical timeline

DateEventClaims
June 12, 1924Born in Milton, Massachusetts.CLM-0001
May 4, 1991Atrial fibrillation while running; admitted to hospital; ECG and cardiac ultrasound otherwise normal.CLM-0002
May 6, 1991Sinus rhythm restored on medication; discharged.CLM-0003, CLM-0004
May 1991Diagnosed with Graves' disease later the same week.CLM-0005
Later in 1991 (month not verified)Radioactive iodine for Graves' disease; weight loss partly regained; thyroid hormone level later low, and thyroid hormone replacement begun.CLM-0006, CLM-0007
March 26, 1992Physical examination: thyroid function normal on Synthroid 0.15 mg a day; normal ECG.CLM-0008
November 30, 2018Died at 94.CLM-0009

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D George Herbert Walker Bush was born in Milton, Massachusetts, on June 12, 1924. confirmed George H. W. Bush (presidential biography) supports
D On May 4, 1991, he developed atrial fibrillation while running at Camp David; it presented as unusual fatigue during the run. He was flown to Bethesda Naval Hospital, where an electrocardiogram showed no abnormality except the irregular rhythm and a cardiac ultrasound showed no structural abnormality and normal heart function. Treatment began with digoxin.
White House statement issued the same evening.
confirmed Statement by Press Secretary Fitzwater on the President's Health, May 4, 1991 supports
D On May 5, 1991, the White House said he still had atrial fibrillation, with no sign of heart damage or heart attack, and that procainamide had been added to digoxin; electrical cardioversion would be considered if the rhythm did not return to normal. confirmed Statement by Press Secretary Fitzwater on the President's Health, May 5, 1991 (morning) supports
Statement by Press Secretary Fitzwater on the President's Health, May 5, 1991 (evening) supports
D His normal rhythm returned late on May 5, atrial fibrillation recurred early on May 6, and cardioversion was judged unnecessary because his response to medication was encouraging. He was discharged on May 6 and was in normal sinus rhythm later that day, on digoxin and procainamide. confirmed Statement by Press Secretary Fitzwater on the President's Health, May 6, 1991 (morning) supports
Statement by Press Secretary Fitzwater on the President's Health, May 6, 1991 (evening) supports
D Later in the same week he was diagnosed with Graves' disease.
Editorial note to the May 4 statement in the Public Papers.
confirmed Statement by Press Secretary Fitzwater on the President's Health, May 4, 1991 supports
D A physician's account published in 2016 reports a ventricular rate of 150 beats per minute on arrival at the hospital, an overactive thyroid as the explanation for the atrial fibrillation, treatment with an oral dose of radioactive iodine, a thyroid hormone level that became too low within a few months, and synthetic thyroid hormone thereafter for life.
Secondary account by a physician writing for a newspaper; the exact date of the radioactive iodine treatment was not verified.
probable Schwartz AB. Medical Mystery: A president's love of exercise reveals an issue supports
D Newsweek reported that he had regained eight of the 13 pounds he lost after doctors used radioactive iodine to control his overactive thyroid.
News report; the article date was not verified.
probable Bush Health Mystery supports
D After his physical examination on March 26, 1992, the White House reported that his thyroid function remained completely normal on Synthroid 0.15 milligrams a day, that his electrocardiogram was normal and there was no evidence of heart disease, that hip and neck x-rays showed mild degenerative osteoarthritis, and that raised pressure in his left eye was stable without signs of glaucoma.
Confirms lifelong levothyroxine replacement and sinus rhythm after treatment. Later than the episode; recorded in the claims only.
confirmed Statements by Press Secretary Fitzwater on the President's Physical Examination, March 26, 1992 supports
D He died on November 30, 2018, at the age of 94. confirmed George H. W. Bush (presidential biography) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillation active confirmed both_with_link CLM-0002, CLM-0003, CLM-0004
S Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' disease active confirmed both_with_link CLM-0005, CLM-0006
S Hypothyroidism after radioactive iodine, on levothyroxine replacement active confirmed both_with_link CLM-0006, CLM-0008

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-05-08 Thyrotropin [Units/volume] in Serum or Plasma 0.005 mIU/L (low)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-05-08 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 3.6 ng/dL (high)
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-05-08 Triiodothyronine (T3) [Mass/volume] in Serum or Plasma 280 ng/dL (high)
Reference 80-200 ng/dL
http://loinc.org · 3053-6
S 2026-05-08 Thyrotropin receptor Ab [Units/volume] in Serum 8.2 [IU]/L (high)
Reference <=1.75 [IU]/L
http://loinc.org · 5385-0
S 2026-05-08 Leukocytes [#/volume] in Blood by Automated count 6.8 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-05-08 Neutrophils [#/volume] in Blood by Automated count 3.9 10*3/uL
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 2026-05-08 Hemoglobin [Mass/volume] in Blood 14.8 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 2026-05-08 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 32 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-05-08 Creatinine [Mass/volume] in Serum or Plasma 0.92 mg/dL
Reference 0.7-1.3 mg/dL
http://loinc.org · 2160-0
S 2026-05-08 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 87 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-08 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-20 Thyrotropin [Units/volume] in Serum or Plasma 0.01 mIU/L (low)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-05-20 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 2.2 ng/dL (high)
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-05-20 Triiodothyronine (T3) [Mass/volume] in Serum or Plasma 176 ng/dL
Reference 80-200 ng/dL
http://loinc.org · 3053-6
S 2026-05-20 Neutrophils [#/volume] in Blood by Automated count 3.5 10*3/uL
Reference 1.5-7.5 10*3/uL
http://loinc.org · 751-8
S 2026-05-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-07-17 Thyrotropin [Units/volume] in Serum or Plasma 5.6 mIU/L (high)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-07-17 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 0.6 ng/dL (low)
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-07-17 Triiodothyronine (T3) [Mass/volume] in Serum or Plasma 78 ng/dL (low)
Reference 80-200 ng/dL
http://loinc.org · 3053-6
S 2026-09-11 Thyrotropin [Units/volume] in Serum or Plasma 6.4 mIU/L (high)
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-09-11 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 0.9 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 2026-10-16 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-16 Total score [Mini-Cog] 5 http://loinc.org · 72233-0
S 2026-10-16 Total score [AUDIT-C] 1 http://loinc.org · 75626-2
S 2026-10-16 Thyrotropin [Units/volume] in Serum or Plasma 2.6 mIU/L
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-10-16 Cholesterol [Mass/volume] in Serum or Plasma 186 mg/dL
Reference <=200 mg/dL
http://loinc.org · 2093-3
S 2026-10-16 Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-10-16 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 108 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2026-10-16 Triglyceride [Mass/volume] in Serum or Plasma 100 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-10-16 Hemoglobin A1c/Hemoglobin.total in Blood 5.4%
Reference <=5.6%
http://loinc.org · 4548-4

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-05-08Body height188 cm8302-2S
2026-05-08Body weight86 kg29463-7S
2026-05-08Body mass index (BMI) [Ratio]24.3 kg/m239156-5S
2026-05-08Systolic blood pressure142 mm[Hg]8480-6S
2026-05-08Diastolic blood pressure68 mm[Hg]8462-4S
2026-05-08Heart rate88 /min8867-4S
2026-05-08Respiratory rate16 /min9279-1S
2026-05-08Body temperature37.1 Cel8310-5S
2026-05-08Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-05-20Body height188 cm8302-2S
2026-05-20Body weight86.4 kg29463-7S
2026-05-20Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2026-05-20Systolic blood pressure132 mm[Hg]8480-6S
2026-05-20Diastolic blood pressure70 mm[Hg]8462-4S
2026-05-20Heart rate72 /min8867-4S
2026-05-20Respiratory rate14 /min9279-1S
2026-05-20Body temperature36.9 Cel8310-5S
2026-05-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-17Body height188 cm8302-2S
2026-07-17Body weight88.6 kg29463-7S
2026-07-17Body mass index (BMI) [Ratio]25.1 kg/m239156-5S
2026-07-17Systolic blood pressure128 mm[Hg]8480-6S
2026-07-17Diastolic blood pressure76 mm[Hg]8462-4S
2026-07-17Heart rate64 /min8867-4S
2026-07-17Respiratory rate14 /min9279-1S
2026-07-17Body temperature36.6 Cel8310-5S
2026-07-17Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-09-11Body height188 cm8302-2S
2026-09-11Body weight90.2 kg29463-7S
2026-09-11Body mass index (BMI) [Ratio]25.5 kg/m239156-5S
2026-09-11Systolic blood pressure126 mm[Hg]8480-6S
2026-09-11Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-11Heart rate62 /min8867-4S
2026-09-11Respiratory rate14 /min9279-1S
2026-09-11Body temperature36.6 Cel8310-5S
2026-09-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-16Body height188 cm8302-2S
2026-10-16Body weight90.8 kg29463-7S
2026-10-16Body mass index (BMI) [Ratio]25.7 kg/m239156-5S
2026-10-16Systolic blood pressure128 mm[Hg]8480-6S
2026-10-16Diastolic blood pressure78 mm[Hg]8462-4S
2026-10-16Heart rate68 /min8867-4S
2026-10-16Respiratory rate14 /min9279-1S
2026-10-16Body temperature36.7 Cel8310-5S
2026-10-16Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Resting heart rate below 110 per minute without palpitations while thyrotoxic2026-05-20completedHeart rate 72 in sinus rhythm on metoprolol two weeks after intake
No atrial fibrillation once no longer thyrotoxic, confirmed by ambulatory monitoring before the anticoagulation decision2026-09-11completedSinus rhythm throughout a 14-day ECG patch
TSH within 0.4 to 4.0 mIU/L on levothyroxine2026-10-16completedTSH 6.4 on 75 mcg at the four-month review; 2.6 five weeks after the increase to 100 mcg
Back to running three miles several days a week without symptoms2026-09-11completedRunning three miles four days a week without palpitations

Interventions

InterventionStatusGuideline
Rate control with metoprolol succinate 50 mg daily; no antiarrhythmic drug or cardioversion while thyrotoxic, because most thyrotoxic atrial fibrillation reverts once thyroid levels are normal; taper the beta-blocker once he is no longer thyrotoxiccompletedGL-ACC-AF-2023, GL-CMID-2026, GL-ATA-HYPER-2016
Stroke-risk and bleeding-risk scoring (CHA2DS2-VASc 1 for age 65 to 74; HAS-BLED 1 for age over 65) with a shared decision to continue apixaban 5 mg twice daily while thyrotoxic, then reassess once sustained sinus rhythm is confirmed after he is no longer thyrotoxiccompletedGL-ACC-AF-2023, GL-CMID-2026
Methimazole 20 mg daily after a baseline blood count and liver tests, with written advice to stop it and call at once for fever, sore throat, mouth ulcers, jaundice, or dark urine; stop three days before radioactive iodinecompletedGL-ATA-HYPER-2016
Endocrinology consultation to confirm Graves' disease, assess the eyes, and choose definitive treatment (radioactive iodine, long-term methimazole, or surgery)completedGL-ATA-HYPER-2016
After radioactive iodine: free T4 and total T3 within one to two months and then every four to six weeks until stable; levothyroxine once hypothyroid, started below full replacement; TSH four to eight weeks after each dose change, at six months once stable, then yearly; target TSH 0.4 to 4.0 mIU/LcompletedGL-ATA-HYPER-2016, GL-ATA-HYPO-2014, GL-CMID-2026
Atrial fibrillation monitoring at every visit (heart rate and rhythm, blood pressure, weight, symptoms, activity, alcohol, tobacco), ECG when indicated, echocardiogram at diagnosis, CHA2DS2-VASc and HAS-BLED yearly, creatinine and blood count at baseline and yearly on apixaban, and sleep apnea screening at diagnosis and yearlycompletedGL-ACC-AF-2023, GL-CMID-2026
Return to running in steps once the heart rate is controlled, aiming for about 210 minutes a week of moderate to vigorous activity; limit alcohol to no more than one drink a daycompletedGL-ACC-AF-2023, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 George H. W. Bush (presidential biography) The White House (archived site) government
SRC-0002 Statement by Press Secretary Fitzwater on the President's Health, May 4, 1991 U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), p. 473 primary
SRC-0003 Statement by Press Secretary Fitzwater on the President's Health, May 5, 1991 (morning) U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), pp. 473-474 primary
SRC-0004 Statement by Press Secretary Fitzwater on the President's Health, May 5, 1991 (evening) U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), pp. 474-475 primary
SRC-0005 Statement by Press Secretary Fitzwater on the President's Health, May 6, 1991 (morning) U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), p. 475 primary
SRC-0006 Statement by Press Secretary Fitzwater on the President's Health, May 6, 1991 (evening) U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1991, Book I), pp. 478-479 primary
SRC-0007 Statements by Press Secretary Fitzwater on the President's Physical Examination, March 26, 1992 U.S. Government Publishing Office, Public Papers of the Presidents of the United States: George H. W. Bush (1992, Book I), p. 506 primary
SRC-0008 Schwartz AB. Medical Mystery: A president's love of exercise reveals an issue The Philadelphia Inquirer other
SRC-0009 Bush Health Mystery Newsweek other
SRC-0010 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the anticoagulation decision at CHA2DS2-VASc 1, the methimazole pretreatment, the levothyroxine starting dose, and the deviation recorded for the late sleep apnea screen.
provenance reviewnot_startedRecent-death rule: only White House statements in the Public Papers of the Presidents, a physician's newspaper account, a news report, and the White House biography are used. No political content; no relative's health is used.
safe messaging reviewnot_startedNo behavioral-health diagnosis; no sensitive claims; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.